Announcements Trials

Browse Landscape

Status

Recruiting 36 Active not recruiting 19 Completed 8 Not yet recruiting 6 Suspended 3 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Glioma 1 Carcinoma, Renal Cell 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Glioma × 30 days × Clear all

NCT06743100 2026-05-29

18F-Floretyrosine Expanded Access Program

Telix Pharmaceuticals (Innovations) Pty Limited

No longer available

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡